Phase II trial of preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by postoperative gemcitabine (GEM) in patients (pts) with borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC)
作者
Jae Ho Jeong,Changhoon Yoo,K.-P. Kim,Heung-Moon Chang,Baek‐Yeol Ryoo